Home About company history achievements our team Products Research Markets Contact News	Carl Porter, Ph.D. - Dr. Porter is Leader of the Therapeutics Program within the Grace Cancer Drug Center of the Roswell Park Cancer Institute in Buffalo, New York. He is an accomplished scientist and expert in the research and pre-clinical development of anticancer agents. Dr. Porter has written and published more than 150 scientific articles, delivered more than 50 scientific presentations, and has been awarded five patents. He has received more than $16 million in grant support to date. He received a B.S. from Westminster College, an M.S. from West Virginia University, and a Ph.D. from the State University of New York at Buffalo. Dr. Porter currently holds several nationally peer-reviewed research grant awards. He is an Associate Editor of Cancer Research and participates in various NIH review activities.